The relationship between glucose metabolism, resting-state fMRI BOLD signal, and GABA A -binding potential: A preliminary study in healthy subjects and those with temporal lobe epilepsy

Journal of Cerebral Blood Flow and Metabolism

Volumn 35, Issue , 2015, Pages 583-591

  Nugent, Allison C ^a   Martinez, Ashley ^b   D'Alfonso, Alana ^b   Zarate, Carlos A ^a   Theodore, William H ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

functional connectivity; GABA; glucose metabolism; glutamate; resting state; temporal lobe epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ETIRACETAM; FLUMAZENIL C 11; FLUORODEOXYGLUCOSE F 18; GLUTAMIC ACID; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TRACER; TRAZODONE; GLUCOSE; OXYGEN;

ARTICLE; BOLD SIGNAL; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC SYSTEM; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; SEIZURE; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; ADULT; BLOOD; BRAIN MAPPING; FEMALE; MALE; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; YOUNG ADULT;

ADULT; BRAIN; BRAIN MAPPING; EPILEPSY, TEMPORAL LOBE; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUCOSE; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 84926517255     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.228     Document Type: Article

References (45)

1. Hanai T. Quality of life in children with epilepsy. Epilepsia 1996; 37(Suppl 3); 28-32.
2. Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia 1997; 38(Suppl 1)S1-S8.
3. Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999; 53: 162-166.
4. Lhatoo SD, Johnson AL, Goodridge DM, MacDonald BK, Sander JW, Shorvon SD. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001; 49: 336-344.
5. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319.
6. Avoli M, Louvel J, Pumain R, Kohling R. Cellular and molecular mechanisms of epilepsy in the human brain. Prog Neurobiol 2005; 77: 166-200.
7. Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr 2011; 11: 56-63.
8. Padma MV, Simkins R, White P, Satter M, Christian BT, Dunigan K et al. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Neurol India 2004; 52: 457-462.
9. Hammers A, Koepp MJ, Labbe C, Brooks DJ, Thom M, Cunningham VJ et al. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001; 56: 897-906.
10. Szelies B, Weber-Luxenburger G, Mielke R, Pawlik G, Kessler J, Pietrzyk U et al. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry. Eur J Neurol 2000; 7: 393-400.
11. Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 1996; 119: 1677-1687.
12. Frankle WG, Cho RY, Mason NS, Chen CM, Himes M, Walker C et al. [11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels. PLoS One 2012; 7: e32443.
13. Pearl PL, Gibson KM, Quezado Z, Dustin I, Taylor J, Trzcinski S et al. Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology 2009; 73: 423-429.
14. Kumar A, Semah F, Chugani HT, Theodore WH. Epilepsy diagnosis: positron emission tomography. Handb Clin Neurol 2012; 107: 409-424.
15. Magistretti PJ, Pellerin L. The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies. Mol Psychiatry 1996; 1: 445-452.
16. Willmann O, Wennberg R, May T, Woermann FG, Pohlmann-Eden B. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis. Seizure 2007; 16: 509-520.
17. Cataldi M, Avoli M, de Villers-Sidani E. Resting state networks in temporal lobe epilepsy. Epilepsia 2013; 54: 2048-2059.
18. Haneef Z, Lenartowicz A, Yeh HJ, Levin HS, Engel J Jr., Stern JM. Functional connectivity of hippocampal networks in temporal lobe epilepsy. Epilepsia 2014; 55: 137-145.
19. Tomasi D, Wang GJ, Volkow ND. Energetic cost of brain functional connectivity. Proc Natl Acad Sci USA 2013; 110: 13642-13647.
20. Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci USA 2010; 107: 17757-17762.
21. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York State Psychaitric Institute, Biometrics Research: New York, NY, 2002.
22. Initiative NG. Family Interview for Genetic Studies (FIGS). National Institute of Mental Health: Rockville, MD, 1992.
23. Moore DF, Altarescu G, Barker WC, Patronas NJ, Herscovitch P, Schiffmann R. White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 2003; 62: 231-240.
24. Brooks RA. Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 1982; 23: 538-539.
25. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007; 27: 1533-1539.
26. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishers: New York, NY, 1988.
27. Birn RM, Smith MA, Jones TB, Bandettini PA. The respiration response function: the temporal dynamics of fMRI signal fluctuations related to changes in respiration. Neuroimage 2008; 40: 644-654.
28. Taylor PA, Saad ZS. FATCAT: (an efficient) Functional and Tractographic Connectivity Analysis Toolbox. Brain Connect 2013; 3: 523-535.
29. Zang YF, He Y, Zhu CZ, Cao QJ, Sui MQ, Liang M et al. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev 2007; 29: 83-91.
30. Saad ZS, Reynolds RC, Jo HJ, Gotts SJ, Chen G, Martin A et al. Correcting brainwide correlation differences in resting-state FMRI. Brain Connect 2013; 3: 339-352.
31. Driesen NR, McCarthy G, Bhagwagar Z, Bloch M, Calhoun V, D'Souza DC et al. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry 2013; 18: 1199-1204.
32. Hasler G, Bonwetsch R, Giovacchini G, Toczek MT, Bagic A, Luckenbaugh DA et al. 5-HT(1A) receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 2007; 62: 1258-1264.
33. Nugent AC, Bain EE, Carlson PJ, Neumeister A, Bonne O, Carson RE et al. Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression. Eur Neuropsychopharmacol 2013; 23: 822-829.
34. Duncan NW, Wiebking C, Tiret B, Marjanska M, Hayes DJ, Lyttleton O et al. Glutamate concentration in the medial prefrontal cortex predicts restingstate cortical-subcortical functional connectivity in humans. PLoS One 2013; 8: e60312.
35. Huberfeld G, Menendez de la Prida L, Pallud J, Cohen I, Le Van Quyen M, Adam C et al. Glutamatergic pre-ictal discharges emerge at the transition to seizure in human epilepsy. Nat Neurosci 2011; 14: 627-634.
36. Bittar RG, Andermann F, Olivier A, Dubeau F, Dumoulin SO, Pike GB et al. Interictal spikes increase cerebral glucose metabolism and blood flow: a PET study. Epilepsia 1999; 40: 170-178.
37. Hur YJ, Lee JS, Lee JD, Yun MJ, Kim HD. Quantitative analysis of simultaneous EEG features during PET studies for childhood partial epilepsy. Yonsei Med J 2013; 54: 572-577.
38. Stefanovic B, Warnking JM, Kobayashi E, Bagshaw AP, Hawco C, Dubeau F et al. Hemodynamic and metabolic responses to activation, deactivation and epileptic discharges. Neuroimage 2005; 28: 205-215.
39. Arnold S, Schlaug G, Niemann H, Ebner A, Luders H, Witte OW et al. Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy. Neurology 1996; 46: 1422-1430.
40. Wong CH, Bleasel A, Wen L, Eberl S, Byth K, Fulham M et al. The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia 2010; 51: 1365-1373.
41. Melo TM, Nehlig A, Sonnewald U. Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy. J Cereb Blood Flow Metab 2005; 25: 1254-1264.
42. Smeland OB, Hadera MG, McDonald TS, Sonnewald U, Borges K. Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice. J Cereb Blood Flow Metab 2013; 33: 1090-1097.
43. Schwartz TH. Neurovascular coupling and epilepsy: hemodynamic markers for localizing and predicting seizure onset. Epilepsy Curr 2007; 7: 91-94.
44. Zhang Z, Lu G, Zhong Y, Tan Q, Chen H, Liao W et al. fMRI study of mesial temporal lobe epilepsy using amplitude of low-frequency fluctuation analysis. Hum Brain Mapp 2010; 31: 1851-1861.
45. Tremblay S, Beaule V, Proulx S, de Beaumont L, Marjanska M, Doyon J et al. Relationship between transcranial magnetic stimulation measures of intracortical inhibition and spectroscopy measures of GABA and glutamate+glutamine. J Neurophysiol 2013; 109: 1343-1349.